Skip to main content

Advertisement

Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss

Fig. 10

Hypothetical scheme helps in understanding the mechanism of Chrysosplenetin in Wnt/β-catenin pathway. (DKK1, Dickkopf-related protein 1; CHR, Chrysosplenetin; RUNX2, Runt Related Transcription Factor 2; BGLAP, Osteocalcin; CTNNB1, β-catenin; BMP2, Bone Morphogenetic Protein 2; DLX5, Distal-less Homeobox 5; SPP1, Osteopontin; COL1, Collagen type I; TCF7, Transcription Factor 7; LEF1, Lymphoid Enhancer Binding Factor 1; C-MYC, MYC; CCND1, cyclin D; JUN, c-JUN)

Back to article page